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Year of the Brain in Europe 2014 is important and timely be-
cause across the region we have an ageing population that 
is increasingly in need of effective care and therapies. But 
2014 is also an occasion to celebrate the work of both clini-
cians and the pharmaceutical industry for providing a stan-
dard of healthcare that enables people to lead a good life. 
In the UK a century ago, a man’s life expectancy was just 42 
years of age. This has now risen to 78, and in Japan, a little 
girl born today has a 50-50 chance of living to be 100 years 
old. However, in the wake of these achievements come 
big challenges and one of these is that the longer we live, 
the greater the number of chronic illnesses and brain dis-
eases we will experience. Brain diseases including stroke, 
Parkinson’s disease, and Alzheimer’s disease cause terrible 
distress if poorly managed, and can represent a consider-
able and expensive burden for the healthcare systems. 
Furthermore, another growing problem is that the longer 
we live the more diseases we acquire, so a person over the 
age of 65 will often have more than three or four diseases 
at one time, precipitating a situation where comorbidity 
and polypharmacy will present a major challenge in both 
the near and distant future. 
Pan-EuroPEan challEngEs
We have witnessed unprecedented migration across Eu-
rope; time in consultation with a doctor is just 12 minutes; 
and we are challenged by European states having differ-
ent degrees of access to medicines. With all these chal-
lenges and more, we want to raise awareness in society 
– not just of doctors, nurses, and politicians – but of ordi-
nary families across Europe. What role can they play in the 
management of their illnesses as they age and how can 
they get the best quality of life? 
One of the areas where we can obtain measureable results 
is stroke prevention. How can we educate our publics in 
our respective countries not just about raised blood pres-
sure and cholesterol, but also about the many other risk 
factors associated with stroke? How can we prompt peo-
ple to visit the doctor so that they can access medicines 
earlier to help prevent stroke?
Other significant issues include how we help raise the 
awareness of pain. Pain is unseen, it emanates in the brain, 
it is associated with high costs for labor market, with ab-
senteeism from work, particularly from back pain. What 
can we do about the psychological and psychiatric dis-
eases – depression, schizophrenia, bipolar disorder – 
these are all increasing in incidence, and we know that 
the chance of these people making it to a long life are 
reduced considerably.
How can we help families educate their children as they 
are growing up about the challenges of alcohol? We, at the 
European Brain Council, all believe that alcohol is a greater 
challenge than drugs because drugs are illegal and there 
is a very clear warning against their use. Alcohol and to-
bacco are not illegal, and yet young people are moving 
relentlessly towards reckless using of these stimulants. We 
want to raise awareness that we need good science and 
good clinicians, but also that we want to highlight the 
importance of economics and ethics – why should some 
countries in Europe get things that others do not? The 
voice of the patient is also incredibly important including 
patients’ experiences about what it is like to live daily with 
some of these diseases and what it is like to care for some-
body with these diseases. 
a sEriEs of onE-day confErEncEs across EuroPE
During the Year of the Brain in Europe we want to raise 
these issues in a series of small one-day conferences 
across Europe. We do not know all the needs of all the 
various countries, but as a logo on the conference 
program already says “doing this with the Europe-
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an Brain Council,” we want to make sure that for one day 
in 2014 we work together to raise awareness of how the 
public can actively manage their lives and brain diseases 
in a better way. The European Brain Council has aimed to 
bring together European stakeholders from across various 
specialties related to brain diseases: neurology, psychia-
try, neuroscience, neurosurgery, neuropsychopharmacol-
ogy, patient groups living with neurological illness, and 
patients groups living with mental illness. Although there 
are challenges associated with this due to language differ-
ences, economic availability of medications, culture, and 
information, as an organization, we are trying to provide 
an overarching canopy encompassing individual brain 
councils devising a program that is optimal for each indi-
vidual European country. We are trying to organize brain 
councils in every one of these European countries, and 
gradually the network of national brain councils will be-
come more extensive.
Patient organisations are also of the utmost importance 
to the European Brain Council. They will attend many of 
these conferences and speak about what it is like to live 
with a certain illness, the challenges of trying to get work, 
deal with their children or even their grandchildren, man-
age on transport systems, and to establish what exactly 
would make a difference to their daily lives. In addition, 
there is emphasis on how to improve and encourage joint 
decision making over new therapies, with open discus-
sion of benefit and risk between doctor and patient. 
A major objective of the European Brain Council is to en-
gage with society. In collaboration with the World Federa-
tion of Neurology, we are in discussion with World Health 
Organization with the aim of organizing a Day of the Brain, 
effectively a special day which could be rolled out world-
wide to discuss issues related to the brain. As a legacy of 
the Year of the Brain in Europe, we hope that the European 
Commission will run a special brain event within the Euro-
pean Parliament. Hopefully, such a meeting could evolve 
into a meeting similar to that in Davos, where all the world’s 
economic leaders meet. At that sort of a policy level in the 
real world, I hope that we might be able to show that we 
have reduced the number of stroke cases across Europe, 
because that would have measureable impact.
There are also certain policy-related activities that we aim 
to do. For example, we aim to encourage all cyclists in Eu-
rope to protect their brains by wearing helmets and to 
help young university students to limit drinking. Also, we 
would like to see childhood brain diseases receive more 
attention than that received at the moment. Attention 
deficit Hyperactivity Disorder (ADHD), autism, and some 
of rare neuropediatric illnesses benefit from very little re-
search and funding.  
In addition, there are also illnesses for which young wom-
en take medications from early ages – epilepsy, bipolar 
disorder, schizophrenia – and yet little is known on how 
these drugs effect their bodies in the long term and how 
this manifests in effects on the fetus and uterus during 
pregnancy. Women have been excluded from the clinical 
trials for over 50 years because of the thalidomide disaster. 
What revisions are needed in clinical trials because they 
exclude most people over the age of 60 and yet the popu-
lations most in need of therapies are 60 years plus? How 
can clinical trials be developed to account for the many 
co-morbidities older people have? Should there be a new 
regulatory system? How could we help to improve regu-
lations in Europe, because the one thing we are not short 
of is wonderful science, but sometimes that science is not 
underpinned by humanities and ethics?
We also hope that the all these efforts will not just be 
about curing diseases, but about looking at what the 
brain has achieved for mankind – the culture, the poetry, 
the drama, the music, because the brain is responsible for 
everything that we do. We want not only to encourage 
more good science, but we also want to ensure some en-
tertainment value. We are planning an event in Brussels 
about neurological illness, featuring dystonia. One of the 
main guests will be a concert flautist with dystonia who 
will play beautiful music illustrating the effect that the dis-
ease has on ability to play. We also have a young concert 
pianist with multiple sclerosis. 
Above all, in whichever European country we live in, our 
mantra is “the national wealth is the brain health.” We want 
to encourage the youth, who are our future, to develop 
their brains, nurture their brains, and above all protect 
their brains. We want to organize events that will educate 
them in this respect, and hopefully will leave a legacy of a 
healthier population. 
